38 completed, 8 unknown, 3 terminated, 1 active not recruiting. 51 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 51 | Completed 38, Unknown 8, Terminated 3, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 6 | Completed 3, Unknown 2, Active not recruiting 1 |
Follow Tinea: new trials by email Literature Review of Tinea trials Research Report on Tinea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working Amphotericine in liposome (Ambisome®) - Tinea Capitis | Phase 2 / Phase 3 | Active not recruiting | Sohag University | 30 | 2025-04-01 | 2025-05-20 |
| Efficacy and Safety of Terbinafine and Itraconazole Terbinafine Tablets, Itraconazole - Tinea Corporis, Tinea Cruris | Phase 2 / Phase 3 | Unknown | Dhaka Medical College | 150 | 2023-05-01 | 2023-05-31 |
| Use of Essential Oils as Natural Therapies application of cream "La Chinata" - Dermatophytoses, Skin Lesion | Phase 3 | Completed | University of Extremadura | 49 | 2023-02-11 | 2023-12-15 |
| A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) MOB015B, Vehicle (Placebo Comparator) - Onychomycosis | Phase 3 | Unknown | Moberg Pharma AB | 350 | 2022-05-09 | 2024-06-26 |
| Efficacy of Intralesional PRP in Treatment of Onychomycosis intralesional platelet rich plasma, Oral terbinafine - Platelet Rich Plasma | Phase 3 | Unknown | Sohag University | 75 | 2021-12-01 | 2021-11-22 |
| A Therapeutic Equivalence Study of Ketoconazole Cream 2% Experimental: Ketoconazole 2% Cream (Douglas Pharmaceuticals America Ltd.), Active comparator: Ketoconazole 2% Cream (Teva Pharmaceuticals USA), Placebo comparator: Placebo (Douglas Pharmaceuticals America Ltd.) - Tinea Pedis | Phase 3 | Completed | Douglas Pharmaceuticals America Ltd | 682 | 2019-12-11 | 2020-08-06 |
| Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis Candicort®, Nizoral®, Baycuten N® - Tinea | Phase 3 | Completed | Ache Laboratorios Farmaceuticos S.A. | 125 | 2019-06-11 | 2021-09-20 |
| Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis Ketoconazole Cream 2%, Ketoconazole Cream 2% (G&W Laboratories Inc.), Placebo - Tinea Pedis | Phase 3 | Completed | Encube Ethicals Pvt. Ltd. | 831 | 2018-08-23 | 2019-06-27 |
| Non-inferiority Trial of Dapaconazole Versus Ketoconazole Dapaconazole, Ketoconazole - Tinea Pedis | Phase 3 | Completed | Biolab Sanus Farmaceutica | 360 | 2017-11-01 | 2020-07-27 |
| Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients Efinaconazole Topical - Onychomycosis | Phase 3 | Completed | Western University of Health Sciences | 40 | 2017-06-06 | 2020-10-30 |
| Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis Nailner 2 in 1, Ciclopirox 8% - Onychomycosis | Phase 3 | Unknown | MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA | 46 | 2017-04-01 | 2017-03-31 |
| Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis Dapaconazole, Ketoconazole - Tinea Pedis | Phase 3 | Withdrawn | Biolab Sanus Farmaceutica | 2016-06-01 | 2017-02-01 | |
| Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis Econazole Nitrate Cream, 1%, Placebo - Tinea Pedis | Phase 3 | Completed | Mylan Inc. | 876 | 2016-03-15 | 2022-03-07 |
| Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis P-3058 10%, vehicle of P-3058 10%, amorolfine 5% - Onychomycosis | Phase 3 | Completed | Polichem S.A. | 953 | 2015-08-20 | 2018-09-26 |
| Design and Clinical Evaluation of a School Meal With Deworming Properties Ujiplus, Albendazole, uji - Helminthiasis, Tinea Capitis | Phase 2 / Phase 3 | Completed | Kenya Medical Research Institute | 326 | 2015-05-01 | 2016-09-07 |
| BE Study of Naftifine HCL Naftifine hydrochloride 2%, Placebo, Naftin® 2% (Naftifine hydrochloride 2%) - Tinea Pedis | Phase 3 | Completed | Genzum Life Sciences | 693 | 2015-03-01 | 2017-05-11 |
| Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population P-3058 - Onychomycosis | Phase 3 | Completed | Polichem S.A. | 20 | 2014-08-01 | 2018-03-08 |
| Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris Naftin 1% Cream, Placebo Cream - Tinea Cruris, Jock Itch | Phase 3 | Completed | Merz North America, Inc. | 65 | 2013-08-01 | 2015-04-15 |
| Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis Luliconazole Solution, 10%, Vehicle Solution - Distal and Lateral Subungual Onychomycosis | Phase 2 / Phase 3 | Completed | Topica Pharmaceuticals | 334 | 2012-05-01 | 2015-11-30 |
| Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections Clotrimazole - Fungal Infections, Tinea Pedis | Phase 3 | Unknown | Laboratório Teuto Brasileiro S/A | 90 | 2012-04-01 | 2012-04-12 |
Showing 20 of 51. Sign in to see all of them.
Onychomycosis (21) · Tinea Pedis (19) · Tinea Cruris (6) · Foot Dermatoses (5) · Mycoses (5) · Tinea Capitis (5) · Dermatomycoses (2) · Keratoderma, Palmoplantar, Epidermolytic (2) · Nails, Malformed (2) · Onycholysis (2) · Twenty-Nail Dystrophy (2) · Yellow Nail Syndrome (2) · Anemia (1) · Cellulitis (1)
Bacterial Infections and Mycoses (51) · Infections (51) · Skin Diseases (51) · Skin and Connective Tissue Diseases (51) · Skin Diseases, Infectious (50) · Dermatomycoses (49) · Mycoses (46) · Foot Diseases (23) · Pathological Conditions, Signs and Symptoms (22) · Nail Diseases (21) · Foot Dermatoses (19) · Signs and Symptoms (19) · Pruritus (18) · Skin Manifestations (18)
Terbinafine (9) · Ketoconazole (4) · naftifine (4) · 1-(2-(2,4-dichlorophenyl)-2-(4-(trifluoromethyl)benzyloxy)ethyl)-1H-imidazole (2) · Clotrimazole (2) · Gels (2) · Itraconazole (2) · Solutions (2) · Albendazole (1) · Calcium Dobesilate (1) · Fluconazole (1) · Griseofulvin (1) · Liposomes (1) · amorolfine (1) · betamethasone-17,21-dipropionate (1)
Merz North America, Inc. (5) · Medicis Global Service Corporation (3) · Novartis (3) · Novartis Pharmaceuticals (3) · Pfizer (3) · AmDerma (2) · Biolab Sanus Farmaceutica (2) · Dow Pharmaceutical Sciences (2) · Polichem S.A. (2) · Promius Pharma, LLC (2) · Sohag University (2) · Ache Laboratorios Farmaceuticos S.A. (1) · Bayer (1) · Celtic Pharma Development Services (1) · Dhaka Medical College (1)
United States (32) · Canada (7) · Belize (6) · Puerto Rico (6) · Germany (5) · Brazil (4) · Dominican Republic (4) · Honduras (4) · Poland (4) · Iceland (3) · Spain (3) · Belgium (2) · Czechia (2) · Egypt (2) · El Salvador (2)
Lawrence Parish, MD (3) · Ron Staugaard (3) · Daniel Piacquadio, MD (2) · Joanne Fraser, PhD (2) · Kent Allenby, MD (2) · Maurizio Caserini, MD (2) · Bernard Goffe, MD (1) · David M Harris, PhD (1) · Eduardo Tschen, MD (1) · Elijah M Songok, PhD (1)
PMID 25007364, PMID 21968664, PMID 22052309, PMID 23884486, PMID 30526582
2008 (1), 2015 (1)